PhRMA: Replace Drug Rebates to PBMs, Insurers with Fees Ties to Value

One of the biopharma industry’s two key trade groups yesterday called for replacing the current system that allows drug manufacturers to offer rebates in return for their medicines being given preference on the formularies of pharmaceutical benefits managers (PBMs), insurers, employer groups, and other entities in the prescription drug supply chain.Pharmaceutical Research and Manufacturers of America (PhRMA) spoke out two months after Trump unveiled his plan for reducing drug prices for Am